ArticleThe Journal of infectious diseases2023

Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed Adults.

Camilo C Roa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.